Peptid-Klartext DE Community
Weight loss & metabolism

Liraglutide: Effects, Evidence and Risks

Also known as Victoza, Saxenda.

StatusApproved (EU)
EvidenceLarge RCTs
Drug classGLP-1 agonist · daily s.c.
Add as vial in trackerCalculate in calculator

We only show doses for approved medicines according to the prescribing information – in the calculator.

What is liraglutide?

The “predecessor” of semaglutide. Works in a similar way, but has to be injected daily and is less effective for weight loss.

How well studied is liraglutide?

SCALE trials: on average around 8% weight loss over one year. In use for many years, so there is good long-term data.

What side effects and risks does liraglutide have?

Nausea, diarrhoea, constipation; rarely pancreatitis and gallstones.

Is liraglutide approved in Germany?

In short: yes. Approved in the EU, prescription-only. Because of the long track record, sometimes an option when newer drugs are not available.

Sources

Note: We deliberately do not list any doses here. For approved medicines, your doctor sets the dose; for unapproved substances there is no reliable information.